Revolutionizing Hemophilia B Treatment

This chapter explores the innovative gene therapy Fidanicogene Leparvovec, designed to treat hemophilia B with a single infusion. It highlights the therapy's promising results in reducing the need for frequent infusions and discusses its impact on patients' lives while maintaining a cautious perspective on its classification as a cure.